Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis
Condition(s):Osteoporosis, PostmenopausalLast Updated:May 1, 2008Completed
Hide Studies Not Open or Pending
Condition(s):Osteoporosis, PostmenopausalLast Updated:May 1, 2008Completed
Condition(s):Rheumatoid ArthritisLast Updated:December 16, 2021Completed
Condition(s):Stage I Prostate Adenocarcinoma; Stage II Prostate AdenocarcinomaLast Updated:January 22, 2019Withdrawn
Condition(s):Osteoporosis, PostmenopausalLast Updated:May 15, 2007Completed
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:January 9, 2020Completed
Condition(s):Negative Symptoms of Schizophrenia in Post-menopausal Women.Last Updated:August 24, 2015Completed
Condition(s):SchizophreniaLast Updated:September 6, 2019Completed
Condition(s):Osteoporosis, Post-MenopausalLast Updated:September 20, 2007Completed
Condition(s):Schizophrenia; Schizoaffective Disorder; Schizophreniform DisorderLast Updated:January 9, 2020Unknown status
Condition(s):OsteopeniaLast Updated:December 30, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.